Hennemann, B <br/><br/>
[Palliative chemotherapy of head and neck cancer: present status and future development].  [electronic resource] 

 -  Laryngo- rhino- otologie  Mar 2006 
 - 172-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review 
<br/><br/><label>ISSN: </label>0935-8943 
<br/><br/><label>Standard No.: </label>10.1055/s-2005-921107  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cisplatin--administration & dosage<br/>Clinical Trials as Topic<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Deoxycytidine--administration & dosage<br/>Disease Progression<br/>ErbB Receptors--antagonists & inhibitors<br/>Forecasting<br/>Gefitinib<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Neoplasm Metastasis<br/>Neoplasm Recurrence, Local--drug therapy<br/>Palliative Care<br/>Patient Selection<br/>Protein Kinase Inhibitors--administration & dosage<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Quinazolines--administration & dosage<br/>Rats<br/>Taxoids--administration & dosage<br/>Time Factors<br/>Treatment Outcome<br/>Vinblastine--administration & dosage<br/>Vinorelbine<br/>Gemcitabine